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Abstract
Purpose: To determine the influence of menstrual irregularity, oral contraceptive use and other
factors on bone mineral density (BMD) and bone size at different skeletal sites in 135 college-aged
fit women.
Methods: Menstrual history, oral contraceptive use, exercise history, and nutritional factors
including calcium, caffeine, and alcohol intake as well as tobacco use were determined by written
survey. Height, weight and fitness levels were measured. Spine and hip BMD were measured by
dual x-ray absorptiometry (DXA), calcaneus BMD by peripheral DXA, and tibial bone mineral
content (BMC) and size by peripheral Quantitative Computed Tomography (pQCT).
Results: The mean age was 18.4 ± 0.8 years. Weight and prior exercise were positively related to
BMD at most skeletal sites and to tibial bone size. Milk intake was positively related to calcaneal
BMD, tibial BMC and cortical thickness. Fracture history was an important predictor of spine, hip
and heel BMD. Women who had ≥ 10 menstrual cycles in the year prior to BMD measurement had
higher BMD at all sites as well as a greater tibial mineral content and cortical thickness than women
who had oligomenorrhea/amenorrhea (≤ 9 cycles in the prior year; all p < 0.05). Oral
Contraceptive (OC) users had significantly lower BMD in the spine (p < 0.02) and calcaneus (p =
0.04), smaller tibial periosteal circumference and lower tibial mineral content (p < 0.02) than non-
OC users.
Conclusion: In a population of fit, college-aged women, OC use and oligomenorrhea were
associated with reduced BMD and bone size. Weight, as well as prior exercise and milk intake was
positively related to bone density and size at some skeletal sites. Understanding these relationships
would help improve skeletal health in young women.
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Background
Osteoporosis is a major public health concern as high-
lighted by the recent Surgeon General's report [1]. A key
osteoporosis prevention strategy is to increase early
accrual of bone mineral density (BMD). A higher BMD
and larger bone size attained in childhood and main-
tained through the third decade of life has been related to
a subsequent reduction in the risk of childhood fracture,
stress fracture, osteoporosis and fractures related to oste-
oporosis later in life [2-5]. Therefore, it is important to
understand factors that can be modified to improve the
accrual of peak bone mass and increase in bone size in
women [6-8].
Genetic factors account for 60–80% of the variance in
peak bone mass [7,8]. Failure to achieve the genetically
pre-determined complement of bone mass is often related
to sub-optimal environmental and lifestyle conditions in
women. Bone accrual can also be limited by eating disor-
ders and oligo- and amenorrhea [9-11]. Oral contracep-
tive (OC) use may have an effect on bone accrual but its
exact role is unclear. There is some evidence attributing a
modest benefit of oral contraceptive use to spine and hip
BMD. Alternatively, several recent studies have shown
either no effect or negative effects of oral contraceptives
on bone density. The impact of OC on bone size is also
not well understood [12-15]. The type of contraception,
age at first use and level of exercise may alter the impact of
OC use on bone health [6,16,17]. Observational studies
of OC use on bone mass may be confounded by the
underlying reason for use as 4–9% of women use oral
contraceptives for reasons other than birth control,
including amenorrhea or oligomenorrhea [18]. There are
many other factors that may positively influence BMD
including high levels of physical activity and adequate cal-
cium intake [6,19,20].
The purpose of this cross sectional study is to examine the
influence of various factors associated with BMD, includ-
ing calcium intake, exercise history, fitness level, body
size, menstrual function and oral contraceptive use on
bone mineral density and bone size in physically fit col-
lege age women.
Methods
Subjects
All cadets entering the United States Military Academy
(USMA) Class of 2002, West Point, NY were sent a study
information packet, including a sample consent form and
study protocol, prior to their arrival at the Academy. The
study objectives and the associated risks were described in
a presentation during their first week at the Academy. Sev-
enty percent of all eligible women in the class agreed to
participate and provided written informed consent. There
were no differences between those who elected to partici-
pate and those who did not with regard to race or age. One
hundred and thirty five women consented to participate
in a 4-year prospective study examining the determinants
of peak bone mass and stress fractures. There are stringent
medical requirements for entrance into USMA that led to
the exclusion of women with severe polycystic ovarian
disease and other diseases that affect BMD, including per-
sons with uncontrolled thyroid disease, epilepsy, gas-
trointestinal disease or long term steroid use (Army
Regulation 40–501, Chapter 2). Race was self-reported on
USMA applications. The largest racial group was Cauca-
sian (n = 107). Therefore analyses will focus on this
group. However, racial differences in bone density will
also be reported. The Institutional Review Board (IRB) of
Keller Army Community Hospital (KACH), West Point,
NY, approved the study.
Lifestyle Assessments
Information on exercise, dietary and other lifestyle factors
in the year prior to entering USMA was collected by ques-
tionnaire, allowing cadets to pick from categories to expe-
dite data collection. Exercise was quantified as the
number of exercise hours per week and divided into four
categories of 1–3, 4–6, 7–10, or 11 + hours per week. Four
questions assessed calcium intake including daily milk
consumption (divided into 4 categories: none, <1, 1–2, or
3 or more 8 ounce glasses per day) and weekly servings of
yogurt, cheese and high calcium content vegetables (0, 1–
3, 4–6 or 7 + serving per week). From these responses, an
average daily calcium intake was calculated (mg/day).
Daily caffeine intake was divided into three categories:
none, 1 to 3 and more than 3 caffeine containing drinks a
day. Alcohol intake was categorized as: less than once a
month, 1–3 times a month, 1 to 2 times a week, and 3 to
5 times a week. Tobacco use was assessed by type (dip,
chew, or cigarettes), dose, and duration. Lifetime history
of personal skeletal fracture and site of fracture were deter-
mined by questionnaire. Cadets reported their age at
menarche, and current and prior use of birth control pills.
Prior use was considered any use of oral contraceptives
(OC) in the past for greater than 3 months. Current users
included individuals taking OC for at least 3 months,
including at entry to USMA. Frequency of menstrual
cycles in the year prior to entering USMA was categorized
as ≤9 cycles per year (amenorrhea/oligomenorrhea), or
10–12 cycles/year (normal) in the past year.
Fitness and Anthropometric Measures
Academy personnel measured each cadet's height and
weight at entry in standard athletic clothing in stocking
feet and height was measured using a standard scale. Body
Mass Index (BMI) was calculated as weight in kilograms
divided by height in meters squared. Trained Academy
personnel administered the Army Physical Fitness Test
(APFT) to all cadets upon entry into USMA. This testNutrition & Metabolism 2007, 4:17 http://www.nutritionandmetabolism.com/content/4/1/17
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measures upper body and abdominal strength and aero-
bic fitness. It includes the number of full body push-ups
and bent leg sit-ups completed in two-minute segments as
well as a timed two-mile run. These three events (sit-ups,
push-ups and a 2 mile run) are then each converted into
an age and gender standardized score ranging from 0–100
[21]. Faster running times, higher numbers of push ups
and sit ups earn higher scores. The sum of these three
scores represents the overall assessment of fitness with a
range of 0–300.
Bone Densitometry
The left total hip and lumbar spine (L1-L4) BMD (gm/
cm2) were measured using a mobile DXA scanner (DPX-
IQ, General Electric-Lunar, Madison WI). The coefficient
of variation (%CV) in vivo was determined by measuring
8 individuals two times with repositioning. The %CV was
1.5% and 1.5% respectively for spine and left total hip in
this population. During this study there was no impact of
movement of the mobile DXA, based on no significant
change in the phantom measurements as part of the daily
quality control program for DXA measurements. BMD (g/
cm2) of the left calcaneus was assessed using peripheral
dual-energy x-ray absorptiometry (pDXA; Pixi, Lunar,
Madison, WI). The coefficient of variation in vivo for the
calcaneus pDXA was 1.0%. Peripheral QCT (Stratec
XCT2000; Germany) was used to image a single slice at
the distal tibia. To identify the site, the distal third of the
tibia was determined by manual measurement of tibial
length between the base of the patella and the styloid
process (to the closest centimeter). The pQCT was posi-
tioned at the distal site after placing a positioning light of
the gantry above the styloid process. The tibia was chosen
because it is a major site of stress fractures in military
cadets [8]. Bone mineral content (mg per 1 mm slice of
bone), cortical thickness (mm), periosteal and endosteal
circumferences (mm) were measured. Cortical bone was
identified at a threshold above 710 mg/cm3. Cortical
thickness was derived using the circular ring model, which
calculates a mean cortical thickness from measures of
total bone area and cortical bone area. The coefficient of
variation was 2.2% for tibial mineral content and 3.2%
for cortical thickness.
Statistical Analysis
Student's t-tests were used to examine the differences in
BMD among dichotomous lifestyle variables and non-
parametric tests were used (Kruskal-Wallis Test) to test dif-
ferences between variables that are not normally distrib-
uted such as menstrual cycle frequency. The relationships
between lifestyle determinants and BMD were examined
using Pearson's correlation analyses and, where appropri-
ate, with linear regression to control for potential con-
founders. Effects of categorical lifestyle variables on BMD
were also assessed using analysis of variance. The level of
significance for alpha was set at 0.05 for these statistical
tests. In Caucasian women, a multiple regression model
was created using all covariates that had biologic plausi-
bility and were significant in univariate analyses and vari-
ables with p < 0.1 were included in the model. All analyses
were performed with SPSS statistical software (Version
13.0 for Windows, SPSS Inc., Chicago IL.)
Results
Population Characteristics
There were 135 women enrolled, including 107 Cauca-
sians, 13 African Americans and 15 Asians. Table 1 pro-
vides a summary of the lifestyle variables from the
baseline questionnaire for the Caucasian women. Overall,
the women cadets in this study had healthy behaviours
with 77% reporting they exercised more than 7 hours a
week, and reporting an average daily calcium intake
approximately equal to the recommended daily intake
(RDI) for this age group (1000 mg calcium per day). Total
APFT score was more than one standard deviation better
than similar aged female recruits that enter basic training,
a group that more closely represents the general popula-
tion [21]. One component of the APFT, the run score
equated to times for the two mile run test that ranged
from 13 minutes 23 seconds to 22 minutes 39, with 50%
of the women running faster than 8.37 pace per mile.
Women on oral contraceptives had a significantly lower
run score than women who never took oral contraceptives
(p = 0.02). There were no other significant differences in
population characteristics between women on oral con-
traceptives as compared to women who never used oral
contraceptives (Table 1). Most women (97%) were
tobacco free, and 10% admitted to consumption of more
than two alcoholic beverages per week (although alcohol
intake may be underestimated in this underage popula-
tion). Thirty-four% of women reported previous fractures.
Approximately 11% of the women currently used oral
contraceptives and there was no reported use of Depo-
Provera. All women had experienced menarche and the
women with oligomenorrhea/amenorrhea reported
reaching menarche a year later than those women with
normal cycles in the past year (p < 0.05; Table 1). There
were no other significant differences between women
with normal cycles and women with oligomenorrhea/
amenorrhea.
Bone Density Measures
T-scores for the entire population were calculated based
on the reference population from Lunar for the spine
(average T-score = +0.6) and for the total hip (average T-
score = +1.2) using the NHANES database. BMD results
for the calcaneus, left total hip, spine (L1-L4) and tibia as
well as tibial dimensions are reported by menstrual func-Nutrition & Metabolism 2007, 4:17 http://www.nutritionandmetabolism.com/content/4/1/17
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tion category (Figure 1) and oral contraceptive use (Figure
2) and discussed below.
Racial Differences
Although there were no significant racial differences in
total hip BMD, African American women had slightly
higher spine and calcaneus BMD when compared to Cau-
casians (p < 0.05). However, all races had significantly
higher calcaneal, spine and hip BMD than the population
average (p < 0.025). African American women had signif-
icantly larger periosteal circumference and tibial mineral
content when compared to the other races (p  < 0.02).
However, there were no racial differences seen in cortical
thickness.
Predictors of BMD in Caucasian Women
Lumbar Spine and Total Hip
Milk consumption and total calcium intake had no effect
on BMD at the spine or hip. There was no effect from caf-
feine, alcohol or smoking on spine or hip BMD. BMD was
slightly higher (3%) in the spine and hip (4%) when com-
paring the highest exercise level to the other levels for the
year prior to entering USMA (hip, p = 0.06; spine, p =
0.14). APFT and run score did not correlate significantly
with spine or total hip BMD. Women with prior fractures
had higher BMD at both the spine (1.26 ± 0.14 vs. 1.20 ±
0.10) and total hip (1.18 ± 0.12 vs. 1.12 ± 0.12) compared
to those who did not have a prior fracture (both p < 0.04).
Age at menarche was not a determinant of spine or hip
BMD. Women who had either amenorrhea or oligomen-
orrhea in the prior year had significantly lower spine and
Table 1: Descriptive variables for Caucasian women (values are mean (standard deviation) unless otherwise stated)
Variable All Women (n = 
107)
Women with 
Normal Cycles (n = 
81)
Women with 
Amenorrhea/
Oligomenorrhea (n 
= 25)
Women on Oral 
Contraceptives (n = 
12)
Women never on 
Oral Contraceptive 
(n = 95)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age 18.4 (± 0.8) 18.4 (± 0.8) 18.6 (± 0.9) 18.6 (± 1.0) 18.4 (± 0.7)
Age of Menarche (years) 12.8 (± 1.2) 12.6 (± 1.1) 13.6 (± 0.9) * 12.5 (± 1.2) 12.9 (± 1.1)
BMI (kg/mg2) 23.0 (± 2.3) 23.3 (± 2.4) 22.6 (± 2.0) 22.8 (± 1.8) 23.2 (± 2.4)
Height (inches) 65.7 (± 2.4) 65.6 (± 2.5) 66.1 (± 1.8) 64.6 (± 3.0) 65.8 (± 2.3)
Weight (pounds) 142 (± 17) 142.4 (± 17.8) 140.6 (± 15.3) 135.3 (± 12.8) 142.6 (± 17.4)
Army Physical Fitness Test 
(APFT 0–300)
207.8 (± 40.9) 206.0 (± 39.3) 215.1 (± 39.3) 188.3 (± 52.3) 211.8 (± 36.6)
Run score (range 0–100) 74 (± 22) 72.3 (± 22.1) 77.7 (± 22.0) 59.9 (± 25.7) # 76.1 (± 20.9)
Calcium Intake (mg/day) 1074 (± 463) 1167 (± 459) 1014 (± 389) 937 (± 419) 1142 (± 449)
Exercise (hrs/week) %, (n)
1–3 3.0 (4) 2.9 (3) 3.4 (1) 0 (0) 1 (1)
4–6 19.5 (26) 19.4 (38) 20.7 (6) 41.7 (5) 15.6 (15)
7–10 33.8 (45) 36.9 (24) 24.1 (7) 33.3 (4) 38.5 (37)
11+ 43.6 (58) 40.8 (42) 51.7 (15) 25.0 (3) 44.8 (43)
Milk (glass/day) %, (n)
0 11.3 (15) 10.7 (11) 13.8 (15) 8.3 (1) 11.5 (11)
<1 29.3 (39) 23.3 (24) 48.3 (14) 25.0 (3) 25.0 (24)
1–2 46.6 (62) 52.4 (54) 27.6 (8) 50.0 (6) 49.0 (47)
3+ 12.8 (17) 13.6 (14) 10.3 (3) 16.7 (2) 14.6 (14)
Caffeinated Drink/Day %, (n)
None 24.1(32) 22.3 (23) 27.6 (8) 33.3 (4) 20.8 (20)
1–3 69.2 (92) 70.9 (73) 65.5 (19) 58.3 (7) 70.8 (68)
3+ 6.8 (9) 6.8 (7) 6.9 (2) 8.3 (1) 8.3 (8)
Alcohol Consumption %, (n)
Less than once a month 66.9 (91) 70.9 (73) 55.2 (16) 66.7 (8) 64.6 (62)
1–3 times a month 21.3 (28) 18.4 (19) 34.5 (10) 16.7 (2) 24.0 (23)
1–2 times a week 8.8 (12) 8.7 (9) 10.3 (3) 8.3 (1) 11.5 (11)
>3 times a week 1.5 (2) 1.9 (2) 0.0 (0) 8.3 (1) 0 (0)
Smokers %, (n) 3.0 (4) 2.9 (3) 3.4 (1) 8.3 (1) 2.2 (2)
History of Fracture (% yes); n 34.1 (46) 38.8 (40) 24.1 (7) 33.3 (4) 37.5 (36)
*p < 0.05 versus women with normal cycles
# p < 0.05 versus women never on oral contraceptivesNutrition & Metabolism 2007, 4:17 http://www.nutritionandmetabolism.com/content/4/1/17
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hip BMD (Figure 1; both p = 0.03). Never-users of OCs
had significantly higher BMD in the spine when com-
pared with current OC users (p = 0.02; Figure 2). Similar
but not significant differences were found at the hip (p =
0.13; Figure 2).
BMI, height and weight were all modestly correlated with
both spine BMD (r = 0.23, r = 0.36 and 0.41, all p < 0.01)
and total hip BMD (r = 0.31; r = 0.21, and 0.37; all p <
0.01). Each ten-pound increase in weight was responsible
for an approximate 2.5% increase in BMD.
In a linear regression analysis, approximately 30% of the
variation in BMD at the spine was explained by weight,
cycles per year, current OC use and prior exercise (Table
2). At the total hip 28% of the variation in BMD was
explained by weight, fracture history, number of men-
strual cycles and prior exercise (Table 2).
Calcaneus
Total daily calcium intake was modestly correlated with
calcaneal BMD (r = 0.194; p < 0.05). Women with the
lowest daily milk intake (<1 glass per day), compared to
all higher intakes of milk, had 13% lower calcaneal BMD
(p < 0.01). Caffeine, alcohol, and tobacco usage were not
significantly related to calcaneal BMD in the young
women in our study population. Women with a personal
history of fractures had, on average, 6.7% higher calcaneal
The impact of menstrual function on bone mass and size Figure 1
The impact of menstrual function on bone mass and size. Menstrual function was defined as normal (≥ 10 cycles/year) 
versus oligomenorrhea/amenorrhea (≤ 9 cycles/year). Bone mineral density was measured at the spine, hip and heel; and at the 
tibia, bone mineral content, cortical thickness and endosteal circumference were determined. All values are mean ± standard 
errors.
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BMD than those women with no personal fracture history
(p < 0.03). Prior exercise was significantly correlated with
calcaneal BMD (r = 0.37; p < 0.001).
Age of menarche was not related to calcaneal BMD.
Women who reported either amenorrhea or oligomenor-
rhea had lower calcaneal BMD (Figure 1: p = 0.04). A com-
parison of current OC users to women without OC use
showed lower calcaneal BMD in current OC users (Figure
2; p = 0.04).
BMI and weight were moderately correlated with calca-
neal BMD (r = 0.414 and r = 0.450, both p < 0.01). Neither
height nor fitness parameters were correlated with calca-
neal BMD.
Calcaneal BMD in our population of Caucasian women
was best predicted by body weight, glasses of milk con-
sumed per day and current OC use. These variables
accounted for 27.5% of the variation in calcaneal BMD
(Table 2). Each additional 10 pounds of body weight was
associated with a 0.02 g/cm2 increase in calcaneal BMD.
Tibial Mineral Content and Geometry
Women with low milk intake had 6% lower tibial mineral
content than those drinking 3 or more glasses of milk
daily (p = 0.06). There was a marginal difference in corti-
cal thickness at different milk intakes (p < 0.08) but there
was no effect of milk on periosteal circumference. Total
daily calcium intake had no apparent effect on tibial min-
eral content or geometry in our population. Caffeine
The impact of oral contraceptive use on bone mass and size Figure 2
The impact of oral contraceptive use on bone mass and size. Oral contraceptive use was defined as OC use for at 
least three months versus never users. Bone mineral density was measured in these two groups at the spine, hip and heel; at 
the tibia, bone mineral content, cortical thickness and periosteal circumference were measured. All values are mean ± standard 
errors.
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intake had a borderline significant negative impact on tib-
ial mineral content (p = 0.07), but no relationship with
cortical thickness or periosteal circumference. There was
no relationship between smoking or alcohol with tibial
BMC, cortical thickness or periosteal circumference. There
was no association seen between prior fracture and any
tibial parameter.
Women reporting the lowest exercise category had 8%
lower tibial cortical thickness and 6% lower tibial mineral
content than women reporting the highest exercise levels.
Additionally, when comparing the two highest groups
with the two lowest exercise groups there was a significant
difference in both cortical thickness (p > 0.01) and tibial
mineral content (p > 0.04) but not periosteal circumfer-
ence.
There was no significant relationship between age of
menarche and any of the tibial parameters. Those women
with oligomenorrhea or amenorrhea in the year prior to
entering USMA had significantly smaller cortical thickness
(p = 0.001) in part related to a larger endosteal circumfer-
ence (p = 0.01), and these women also had significantly
lower tibial BMC (p < 0.02; Figure 1). As compared to OC
users, tibial BMC was higher and periosteal circumference
was larger in non-OC users (both p = 0.02; Figure 2).
There was slightly larger cortical thickness in non-OC
users as compared to OC users (p = 0.08; Figure 2).
Height was positively correlated with tibial BMC (r = 0.39;
p  > 0.01), and periosteal circumference (r = 0.34; p  >
0.01), but not with cortical thickness. Weight was posi-
tively correlated with the three tibial parameters: tibial
BMC (r = 0.58; p > 0.01), cortical thickness (r = 0.25; p >
0.01), and periosteal circumference (r = 0.50; p > 0.01).
BMI was moderately correlated with tibial mineral con-
tent (r = 0.43; p > 0.01), cortical thickness (r = 0.27; p <
0.01) and periosteal circumference (r = 0.43; p > 0.01). Of
the fitness measures, run score was modestly correlated
with both tibial mineral content and cortical thickness (r
= 0.23, r = 0.24, respectively, both p < 0.04) but not peri-
osteal circumference. APFT was not correlated with any
tibial parameter.
Results of the regression analyses for each of the tibial
parameters in Caucasian women are presented in Table 3.
Regular menstrual function or OC usage and weight were
important predictors in all models, while run score was
important for only tibial mineral content and cortical
thickness.
Discussion
In this cohort of 107 young Caucasian women, we found
that weight was an important and consistent positive
determinant of bone mass at all skeletal sites and of tibial
cortical thickness and periosteal circumference. Prior exer-
cise levels were positively related to calcaneal BMD, tibial
BMC and cortical thickness, and in multivariable models
predicted tibial mineral content and spine and hip BMD.
A component of physical fitness, run score, predicted tib-
ial BMC and cortical thickness. Milk consumption had an
important influence on bone density of the heel and was
marginally related to tibial BMC and cortical thickness.
Prior studies have suggested that milk-based calcium
intake is an important factor in increasing bone density
and bone size [19,20]. The use of oral contraceptives had
a negative effect on calcaneal and spine BMD, tibial min-
eral content and bone size as evidenced by a smaller peri-
osteal circumference at the tibia. We found that one of the
strongest negative predictors of bone density was oli-
gomenorrhea that occurred in 13% of women or amenor-
rhea that occurred in 5% of this population. This
prevalence of amenorrhea/oligomenorrhea is slightly
higher than what has been reported in a Danish study
[22], although the Danish population was likely to have
had lower levels of exercise than these women entering
the USMA. In fact, women in USMA who had oligomen-
orrhea or amenorrhea (32% of whom were avid exercisers
with >11 hours exercise/week) had lower bone mineral
density at all skeletal sites (spine, hip and heel), less BMC
Table 2: Multiple linear regression models for bone density in Caucasian females
Calcaneal BMD 0.118 +0.002(weight) +0.021(milk intake) +0.049(current OC 
use)
(SE) 0.080 0.001 0.009 0.025
p 0.141 0.001 0.024 0.052
R2 = 0.275
Spine BMD 0.461 +0.003(weight) +0.035(cycles/year) +0.062(current OC 
use)
+0.025(exercise)
(SE) 0.125 0.001 0.013 0.036 0.014
p 0.001 0.001 0.011 0.087 0.078
R2 = 0.313
Total Hip BMD 0.617 +0.003(weight) -0.049(fracture hx) +0.035(cycle/year) +0.032 (exercise)
(SE) 0.001 0.001 0.022 0.013 0.014
p 0.001 0.001 0.030 0.010 0.021
R2 = 0.286Nutrition & Metabolism 2007, 4:17 http://www.nutritionandmetabolism.com/content/4/1/17
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at the tibia and a smaller tibial cortical thickness through
an increase in endosteal circumference.
The fact that body weight was an important factor for skel-
etal health is not surprising since genetic factors, includ-
ing weight, can account for between 60–80% of the
variation in BMD [2,8,23,24]. In this extremely fit popu-
lation, weight may have also been related to muscle mass.
In previous studies, high muscle mass has been associated
with higher BMD while low muscle mass was associated
with poor low BMD[25].
The benefits of exercise on bone health are supported by
this study. Both a measure of average weekly exercise in
the prior year and run score, a fitness measure used by the
Army, were found to be important predictors of bone den-
sity at the spine and hip, tibial mineral content and corti-
cal thickness. Long bone cross-sectional growth is also
strongly driven by mechanical load associated with
increased weight and exercise during growth [26] and in
this cohort weight was a significant predictor of periosteal
circumference and exercise and weight influenced cortical
thickness of the tibia.
The high prevalence of prior fracture experienced by the
women in this study (34%) may be related more to an
active lifestyle and selection of activities with higher loads
or greater risk than other women in this age group, rather
than to a difference in bone mass. In fact, a personal his-
tory of fractures was significantly related to higher BMD at
three sites: spine, total hip and calcaneus. There was no
relationship between fractures in these women and paren-
tal fractures. There was no difference in any of the fitness
measures or amount of prior exercise between those with
prior fractures and those without. The type of exercise,
rather than the amount, might have been more important
to personal fracture risk. Alternatively, this could be
explained by the suggestion that individuals with a
genetic predisposition to poor bone quality who engage
in weight bearing exercise, gain more skeletal benefit from
exercise than those without this predisposition [27].
Prior studies evaluating the impact of OC use on BMD at
different skeletal sites has provided mixed results with no
clear consensus[12-14,28]. There is some indication that
OC use at younger ages may suppress endogenous pro-
duction of hormones and that the OC replacement dose
of estrogen is inadequate and may compromise the large
increases in bone mass during peak bone mass accrual
[16]. In this study of young women, 10.7% reported being
current OC users. OC use was associated with significantly
lower bone mineral density at the spine and heel, and
slightly lower BMD at the hip (p = 0.13), in agreement
with several prior studies. Furthermore, we found that OC
users had less tibial BMC and a unique finding of smaller
tibial size (perisoteal circumference). The OC users in this
study did not report higher prior exercise levels or perform
better on the running test. In this study, it was not known
why women were prescribed OCs; it may have been
because of menstrual irregularity or for contraception. If
OCs were used for oligomenorrhea or amenorrhea, the
residual deleterious effects of this could have created the
BMD deficit. However, we did not exclude women with
oligomenorrhea or amenorrhea from the non-OC users
group, which if anything would bias the results toward no
effect of OC on bone.
A unique aspect of our study was the ability to assess peri-
osteal circumference and cortical thickness of the tibia as
important measures of bone size and strength. Menstrual
dysfunction was related to a smaller cortical thickness, in
part, a result of a larger endosteal circumference. Con-
versely, the use of oral contraceptives led to a smaller peri-
osteal circumference and this smaller bone size could
result in less bone strength. A prior study of women aged
18–31 years on oral contraceptives revealed a reduced
cross-sectional area and cross-sectional moment of inertia
in the femoral neck, also indicating reduced mechanical
Table 3: Multiple linear regression table for Caucasian female tibial parameters
Mineral Content 54.836 +10.63(cycles/year) +1.063(weight) +0.395 (run) +6.157 (exercise)
(SE) (27.03) (2.87) (0.15) (0.12) (3.39)
p (0.095) (0.001) (0.001) (0.002) (0.073)
R2 = 0.493
Cortical Thickness 2.141 +0.355(cycles/year) +0.011 (run score) +0.009 (weight)
(SE) (0.696) (0.077) (0.003) (0.004)
p (0.003) (0.001) (0.00) (0.034)
R2 = 0.296
Periosteal 
Circumference
42.42 +0.135 (weight) +2.496 (OC use)
(SE) (4.42) (0.027) (1.377)
p (0.01) (0.001) (0.07)
R2 = 0.272Nutrition & Metabolism 2007, 4:17 http://www.nutritionandmetabolism.com/content/4/1/17
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strength [12]. Thus, as shown elsewhere, an interruption
in normal menstrual function or any alteration in estro-
genic state, such as oral contraceptive use may alter the
mechanostat set point of bone [7]. Periosteal growth,
which enlarges bone diameter, accelerates at puberty in
males. However, in females, periosteal growth is inhibited
by estrogen at puberty [28] and of interest we saw that
females on OCs had a smaller periosteal circumference.
Cortical thickness can also be increased by apposition of
endocortical bone but in females with oligomenorrhea/
amenorrhea this may be prevented, and may in part
explain the significantly larger endosteal circumference
we found in women who have abnormal menstrual func-
tion.
This study had some limitations. Our questionnaire
included only a brief self-administered food frequency
questionnaire. There were many dietary factors not
assessed on our questionnaire that may be important
determinants of bone health including total caloric
intake, but due to time constraints our dietary assessment
had limited scope. Milk consumption was on average very
high in this cohort, limiting ability to see an effect, except
when comparing highest to lowest intakes. Our popula-
tion of women was very fit, with above average BMD,
therefore our external validity is limited. Finally, the
inherent problems associated with cross sectional studies
including the establishment of a temporal relationship
exist in this study.
Conclusion
In conclusion, increased levels of prior exercise and better
running score, a measure of fitness, are positive determi-
nants of BMD at the spine and hip as well as tibial mineral
content and cortical thickness in our population of phys-
ically active young women. Higher milk intake may also
have a positive impact on skeletal health at the heel and
tibia. Physicians, coaches and trainers should consider
menstrual status when examining the health of their ath-
letes, as it appears that oligomenorrhea or amenorrhea
may be important to bone health, having a detrimental
affect on both bone mass and cortical thickness. In addi-
tion, OC use for menstrual irregularity may not be a solu-
tion to menstrual irregularity since there may in fact be
further detrimental impact on bone mass at various skele-
tal sites and bone size as assessed by periosteal circumfer-
ence of the tibia. Attaining a high peak bone mass and
ideal skeletal geometry is important to prevent both stress
fractures and fractures related to osteoporosis later in life
in women. Therefore, longitudinal studies are warranted
to examine the impact of nutrition, exercise, menstrual
function and OC use on accrual of peak BMD as well as
peak bone size.
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